belrosepharma.com rank 381 |
Number of domains linking to belrosepharma.com 1 | semantic flow 0.02 |
Number of links to belrosepharma.com 1 | semantic flow 0.02 |
Number of domains linked from belrosepharma.com 2 | semantic flow 0.17 |
Number of links from belrosepharma.com 2 | semantic flow 0.17 |
On-topic pages from domain with highest topical PageRank.
title / url | |
---|---|
Partnerships | Belrose http://belrosepharma.com/about-us/partnerships/ | |
Belrose Pharma Launched to Develop Innovative Therapeutics for Diseases with High Unmet Medical Needs | Belrose http://belrosepharma.com/belrose-pharma-launched-to-develop-innovative-therapeutics-for-di | |
Contact Us | Belrose http://belrosepharma.com/contact-us/ | |
In-Pharma: Belrose Buys Enzonu2019s Pegylation Platform and Drug Candidates | Belrose http://belrosepharma.com/in-pharma-belrose-buys-enzons-pegylation-platform-and-drug-candid | |
Pharma Deals: Belrose Pharma Acquires Enzonu2019s Advanced Drug Formulation Technology and Associated Clinical Assets | Belrose http://belrosepharma.com/pharma-deals-belrose-pharma-acquires-enzons-advanced-drug-formula |
Relevant domains with most links to selected domain.
domain | |||
---|---|---|---|
http://biopharmguy.com/ | 1 | 0.02 | biopharmguy.com |
Relevant domains with most links from selected domain.
domain | |||
---|---|---|---|
http://pharmaintellect.com/ | 1 | 0.09 | pharmaintellect.com |
http://in-pharmatechnologist.com/ | 1 | 0.08 | in-pharmatechnologist.com |
Pages from domain with most relevant inbound links.
url | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
http://belrosepharma.com/technology-platforms/overview/ | 2 | 0.17 | 0.99 | 0.15 | 1 | yes | 27 | 17 | 0 | 0 | 0 | 0 | |
http://belrosepharma.com/manufacturing-of-cgmp-clinical-batches/ | 1 | 0.16 | 1 | 0.07 | 1 | yes | 30 | 17 | 0 | 0 | 0 | 0 | |
http://belrosepharma.com/proof-of-concept-formulation-development/ | 1 | 0.16 | 0.99 | 0.07 | 1 | yes | 30 | 17 | 0 | 0 | 0 | 0 | |
http://belrosepharma.com/analytical-development-services/ | 1 | 0.16 | 1 | 0.07 | 1 | yes | 30 | 17 | 0 | 0 | 0 | 0 | |
http://belrosepharma.com/careers/ | 1 | 0.16 | 0.99 | 0.07 | 1 | yes | 23 | 13 | 0 | 0 | 0 | 0 | |
http://belrosepharma.com/clinical-development/overview | 1 | 0.16 | 1 | 0.07 | -1 | - | -1 | -1 | -1 | -1 | 0 | 0 | |
http://belrosepharma.com/technology-platforms/other-proprietary-formulation/ | 1 | 0.16 | 0.99 | 0.07 | 1 | yes | 27 | 17 | 0 | 0 | 0 | 0 | |
http://belrosepharma.com/clinical-development/overview/ | 1 | 0.16 | 0.99 | 0.07 | 1 | yes | 27 | 17 | 0 | 0 | 0 | 0 | |
http://belrosepharma.com/partnering/ | 1 | 0.16 | 0.94 | 0.07 | 1 | yes | 30 | 18 | 0 | 0 | 0 | 0 | |
http://belrosepharma.com/ | 1 | 0.15 | 0.99 | 0.02 | 1 | yes | 23 | 13 | 0 | 0 | 1 | 1 |
Pages from domain with most likely on-topic outgoing links.
url | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
http://belrosepharma.com/ | 12 | 0.15 | 0.99 | 0.88 | 1 | yes | 23 | 13 | 0 | 0 | 1 | 1 | |
http://belrosepharma.com/technology-platforms/overview/ | 4 | 0.17 | 0.99 | 0.3 | 1 | yes | 27 | 17 | 0 | 0 | 0 | 0 | |
http://belrosepharma.com/pharma-deals-belrose-pharma-acquires-enzons-advanced-drug-formula | 1 | 0.18 | 0.99 | 0.09 | 1 | yes | 32 | 19 | 1 | 1 | 0 | 0 | |
http://belrosepharma.com/in-pharma-belrose-buys-enzons-pegylation-platform-and-drug-candid | 1 | 0.18 | 0.99 | 0.08 | 1 | yes | 32 | 19 | 1 | 1 | 0 | 0 | |
http://belrosepharma.com/strategic-collaborations-overview/ | 1 | 0.16 | 0.98 | 0.08 | 1 | yes | 31 | 18 | 0 | 0 | 0 | 0 | |
http://belrosepharma.com/proof-of-concept-formulation-development/ | 1 | 0.16 | 0.99 | 0.08 | 1 | yes | 30 | 17 | 0 | 0 | 0 | 0 | |
http://belrosepharma.com/partnering/ | 1 | 0.16 | 0.94 | 0.08 | 1 | yes | 30 | 18 | 0 | 0 | 0 | 0 |
Similar domains to domain, based on inbound linking patterns from other relevant domains. This is also known in SEO as topical co-citation.